Constanze Höbinger

[EASLnews @EASLnews]

In today's #readoftheweek📚, learn how soluble TREM2 reflects liver fibrosis status and predicts postoperative liver dysfunction after liver surgery.

Read this @JHEP_Reports article here: https://t.co/DxnqN2RyUX

🙏@TELL_Santol @D_Rajcic @cohoebinger @TELLRumpf @tgruenberger @TELL_Starlinger @THendrikx1 et al.

#LiverTwitter #LiverX

[Florentina Porsch @FloPorsch]

Excited to share Episode 8 of #AtheroTalk! I had the pleasure of interviewing my inspiring colleague and friend, Dr. Máté Kiss, recipient of the 2024 @society_eas Young Investigator Award, on his award-winning work in @ImmunityCP and beyond!
@MedUni_Wien https://t.co/hiSARecJpU

[Mads Israelsen @IsraelsenMads]

@RuiCastroHD @EASLnews @tom_marjot @PMRodrigues19 @DraMartaAlonsoP @C_V_Schneider @a_zanetto Great interest in the work by young investigators

– we had to stand close together as 12% of all attendees at the SLD Summit joined the YI poster tour

@Pustjens @van Kleef @Dallio
@CiroCelsa @AndreCardador @cohoebinger

[EASLnews @EASLnews]

For the first time ever, the Young Investigators (YI) Taskforce is thrilled to present a YI Poster Session at the EASL #SLDSummit! 🎉

🗓 Date: Friday, 24 Jan 2025
🕒 Time: 13:30 – 14:00 WET

🌍✨ The best YI posters will be presented, with fascinating topics such as:

🔬 PO4-06-YI: Multidisciplinary management improves clinical outcomes in MASLD patients – Marcello Dallio (Italy)
🔬 PO6-19-YI: Alcohol-induced immune-metabolic deregulation in MetALD – Constanze Hoebinger (Austria)
🔬 PO7-12-YI: GLP-1 receptor agonists and reduced liver-related events – Ciro Celsa (Italy)
🔬 PO5-22-YI: RIPK3’s role in MASLD progression – André F. L. Cardador (Portugal)
🔬 PO5-08-YI: Statins vs. aspirin in liver disease – Jesse Pustjens (Netherlands)
🔬 PO5-17-YI: Diagnostic accuracy of non-invasive tests – Laurens A. van Kleef (Netherlands)

Don't miss this opportunity to support Young Investigators and explore innovative research at the forefront of liver health!

🙌 Register now: https://t.co/JV6gj8OaG3

[Eric Topol @EricTopol]

Why intermittent consumption of a high-fat diet may be bad for you; it reprograms macrophages and white blood cells and accelerates atherosclerosis. Succinct summary of 2 recent studies @justsaysinmice https://t.co/n4lWHAzx9R
@cj_binder @NatRevCardiol

[JHEP Reports @JHEP_Reports]

🟪NEW Article in press❕

Soluble TREM2 reflects liver fibrosis status and predicts postoperative liver dysfunction after liver surgery.

🔓#OpenAccess at 👉https://t.co/5eqkCFeyB8

#LiverTwitter
#LiverFibrosis

[Florentina Porsch @FloPorsch]

Thrilled to share our latest review exploring the interface between autoimmunity and atherosclerosis out in @NatRevCardiol today! @cj_binder @MedUni_Wien
https://t.co/982If7UUpd

[Fusion Conferences @Fusion_Conf]

What a group! Our #IMMA24 conference is in full swing, with lots more presentations, networking and our Gala dinner to come over the next few days. It’s been a pleasure working with you all! ☀️��🇽

[Tim Hendrikx @THendrikx1]

🎓🚀 PhD Opportunity! Our lab at MedUni Vienna is now accepting applications for a PhD candidate. Shape the future in Hepatology. Apply by 19.11.2023, 23:55CET at https://t.co/F1jvxImB78.
#PhDOpportunity #Research #Academia #PhDLife #MedUniVienna

[Constanze Höbinger @cohoebinger]

@azinkh96 Congratulations 🥳🎊🎉

[Constanze Höbinger @cohoebinger]

Honored to receive the #esbra2023 travel award! Thanks to @esbra_society and @ISBRAComm 😊

[ESBRA SOCIETY @esbra_society]

👏🏆Congratulations to the recipients of the #esbra2023 travel awards sponsored by @esbra_society and @ISBRAComm!

Una Rastovic
Constanze Hoebinger
Anoisia Courtois
Maszosva Wadzanai
Maria-Emanuela Maxan
Chaowen Zheng
Paula Andres
Nadine Hamieh

[Constanze Höbinger @cohoebinger]

Thanks for the opportunity to talk about our project in Graz!

[ESBRA SOCIETY @esbra_society]

Session 36 #esbra2023 Constanze Hoebinger discusses her new results on the dyslipidemic effects of #alcohol on aortic lesion formation

[Atherosclerosis @ATHjournal]

Reductions in LDL electronegativity are
🔹🤝 to alterations of the LDL lipidome
🔹associated w/ all-cause & CV 💀 byd established risk factors
@KralerSimon @TomLuscher @cmc_uzh @RaberLorenz @liberale_luca @wenzl_florian @UZH_en @society_eas @Texas_Heart
🔗 https://t.co/ybeix0pEz3

[Christoph Binder @cj_binder]

Excited to share our new paper on the surprising role of complement factor H (CFH) in atherosclerosis published in @ImmunityCP today. In the study led by Máté G. Kiss and Nikolina Papac-Miličević, we identified a subset of macrophages expressing CFH. https://t.co/VUj8Vlal8L

[Constanze Höbinger @cohoebinger]

@MFarlik Thanks!

[Constanze Höbinger @cohoebinger]

@azinkh96 @THendrikx1 Thank you 😁

[Constanze Höbinger @cohoebinger]

Excited to see the first paper of my PhD published! Thanks to my PI @THendrikx1

[Frontiers - Endocrinology @FrontEndocrinol]

New Research: Chronic-binge ethanol feeding aggravates systemic dyslipidemia in Ldlr-/- mice, thereby accelerating hepatic fibrosis: Objective

Chronic ethanol consumption is known to cause alcohol-associated liver disease, which… #Endocrinology #Endo https://t.co/B5AUqxpWEo

[Constanze Höbinger @cohoebinger]

@KralerSimon Thanks! 😃

[Constanze Höbinger @cohoebinger]

@THendrikx1 Thanks! :)

[Tim Hendrikx @THendrikx1]

Come to beautiful Vienna! We are hiring a Postdoc and PhD student to study how nutrition and alcohol intake affects immunological pathways, thereby contributing to disease. For more details, write an email to [email protected]. #livertwitter #research #opportunity